Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Infection due to coagulase-negative staphylococci: Clinical manifestations

JoAnn M Tufariello, MD, PhD
Franklin D Lowy, MD
Section Editor
Daniel J Sexton, MD
Deputy Editor
Elinor L Baron, MD, DTMH


Coagulase-negative staphylococci (CoNS) are a major constituent of human skin commensal flora [1,2]. Once considered relatively avirulent and a likely contaminant when isolated from a clinical specimen, these organisms have increasingly been recognized as a cause of clinically significant nosocomial bloodstream infections. Patients at particular risk include those with prosthetic valves, pacemakers, defibrillators, ventricular assist devices, intravascular catheters, or other foreign bodies as well as neonates and immunocompromised hosts. These infections are inherently difficult to treat given the propensity of these organisms to colonize foreign material to form a biofilm and to display resistance to multiple antibiotics [3].

The following discussion will emphasize the issues specific to both native valve endocarditis (NVE) and prosthetic valve endocarditis (PVE) caused by CoNS. Discussion of CoNS infections at other sites is also included. General discussions related to the diagnosis and treatment of infective endocarditis and to the epidemiology, microbiology, pathogenesis, and antibiotic resistance patterns of CoNS are presented separately. (See "Clinical manifestations and evaluation of adults with suspected native valve endocarditis" and "Antimicrobial therapy of native valve endocarditis" and "Epidemiology, clinical manifestations, and diagnosis of prosthetic valve endocarditis" and "Antimicrobial therapy of prosthetic valve endocarditis" and "Infection due to coagulase-negative staphylococci: Epidemiology, microbiology, and pathogenesis" and "Infection due to coagulase-negative staphylococci: Treatment".)


Intravascular catheter infection — Most coagulase-negative staphylococci (CoNS) bloodstream infections are catheter related [4]. For short-term catheters, infection most commonly results from CoNS originating on the patient's skin, migrating via the cutaneous surface of the catheter to gain access to the bloodstream. For longer-term catheters, hub colonization and migration of organisms via the luminal surface is also important.

In general, clinical manifestations may include local erythema and/or drainage, fever, hypotension, and leukocytosis. Diagnosis and management of intravascular catheter infection are discussed further separately. (See "Diagnosis of intravascular catheter-related infections" and "Treatment of intravascular catheter-related infections".)

Distinguishing true infection from skin contamination is important; this is discussed separately. (See "Infection due to coagulase-negative staphylococci: Epidemiology, microbiology, and pathogenesis", section on 'Infection versus contamination'.)

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Sep 2017. | This topic last updated: Aug 24, 2017.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Roth RR, James WD. Microbial ecology of the skin. Annu Rev Microbiol 1988; 42:441.
  2. Grice EA, Kong HH, Conlan S, et al. Topographical and temporal diversity of the human skin microbiome. Science 2009; 324:1190.
  3. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004; 350:1422.
  4. Rogers KL, Fey PD, Rupp ME. Coagulase-negative staphylococcal infections. Infect Dis Clin North Am 2009; 23:73.
  5. Chu VH, Cabell CH, Abrutyn E, et al. Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2004; 39:1527.
  6. Chu VH, Woods CW, Miro JM, et al. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis 2008; 46:232.
  7. López J, Revilla A, Vilacosta I, et al. Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis. Eur Heart J 2007; 28:760.
  8. Gordon SM, Serkey JM, Longworth DL, et al. Early onset prosthetic valve endocarditis: the Cleveland Clinic experience 1992-1997. Ann Thorac Surg 2000; 69:1388.
  9. Castillo JC, Anguita MP, Torres F, et al. Long-term prognosis of early and late prosthetic valve endocarditis. Am J Cardiol 2004; 93:1185.
  10. Piper C, Körfer R, Horstkotte D. Prosthetic valve endocarditis. Heart 2001; 85:590.
  11. Alonso-Valle H, Fariñas-Alvarez C, García-Palomo JD, et al. Clinical course and predictors of death in prosthetic valve endocarditis over a 20-year period. J Thorac Cardiovasc Surg 2010; 139:887.
  12. Caputo GM, Archer GL, Calderwood SB, et al. Native valve endocarditis due to coagulase-negative staphylococci. Clinical and microbiologic features. Am J Med 1987; 83:619.
  13. Petti CA, Simmon KE, Miro JM, et al. Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. J Clin Microbiol 2008; 46:1780.
  14. Williams DN, Peterson PK, Verhoef J, et al. Endocarditis caused by coagulase-negative staphylococci. Infection 1979; 7:5.
  15. Geraci JE, Hanson KC, Giuliani ER. Endocarditis caused by coagulase-negative staphylococci. Mayo Clin Proc 1968; 43:420.
  16. Vandenesch F, Etienne J, Reverdy ME, Eykyn SJ. Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. Clin Infect Dis 1993; 17:871.
  17. Lessing MP, Crook DW, Bowler IC, Gribbin B. Native-valve endocarditis caused by Staphylococcus lugdunensis. QJM 1996; 89:855.
  18. Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007; 297:1354.
  19. Chu VH, Miro JM, Hoen B, et al. Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study. Heart 2009; 95:570.
  20. Amat-Santos IJ, Messika-Zeitoun D, Eltchaninoff H, et al. Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry. Circulation 2015; 131:1566.
  21. van den Broek PJ, Lampe AS, Berbée GA, et al. Epidemic of prosthetic valve endocarditis caused by Staphylococcus epidermidis. Br Med J (Clin Res Ed) 1985; 291:949.
  22. Boyce JM, Potter-Bynoe G, Opal SM, et al. A common-source outbreak of Staphylococcus epidermidis infections among patients undergoing cardiac surgery. J Infect Dis 1990; 161:493.
  23. Karchmer AW, Archer GL, Dismukes WE. Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med 1983; 98:447.
  24. O'Brien T, Collin J. Prosthetic vascular graft infection. Br J Surg 1992; 79:1262.
  25. Leroy O, Meybeck A, Sarraz-Bournet B, et al. Vascular graft infections. Curr Opin Infect Dis 2012; 25:154.
  26. Schreffler RT, Schreffler AJ, Wittler RR. Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr Infect Dis J 2002; 21:632.
  27. Pittet B, Montandon D, Pittet D. Infection in breast implants. Lancet Infect Dis 2005; 5:94.
  28. Sharma M, Berriel-Cass D, Baran J Jr. Sternal surgical-site infection following coronary artery bypass graft: prevalence, microbiology, and complications during a 42-month period. Infect Control Hosp Epidemiol 2004; 25:468.
  29. Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 1992; 20:271.
  30. Gentile RC, Shukla S, Shah M, et al. Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review. Ophthalmology 2014; 121:1634.
  31. Durand ML. Endophthalmitis. Clin Microbiol Infect 2013; 19:227.
  32. Ormerod LD, Ho DD, Becker LE, et al. Endophthalmitis caused by the coagulase-negative staphylococci. 1. Disease spectrum and outcome. Ophthalmology 1993; 100:715.
  33. Hovelius B, Mårdh PA. Staphylococcus saprophyticus as a common cause of urinary tract infections. Rev Infect Dis 1984; 6:328.
  34. Goldstein EJ. Bite wounds and infection. Clin Infect Dis 1992; 14:633.
  35. Anday EK, Talbot GH. Coagulase-negative Staphylococcus bacteremia--a rising threat in the newborn infant. Ann Clin Lab Sci 1985; 15:246.
  36. von Eiff C, Jansen B, Kohnen W, Becker K. Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs 2005; 65:179.